Open Access. Powered by Scholars. Published by Universities.®
Pharmacy and Pharmaceutical Sciences Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Other Pharmacy and Pharmaceutical Sciences (1595)
- Chemicals and Drugs (1258)
- Pharmaceutics and Drug Design (1044)
- Life Sciences (1006)
- Medical Specialties (986)
-
- Medical Sciences (884)
- Medicinal and Pharmaceutical Chemistry (867)
- Public Health (748)
- Diseases (737)
- Pharmacy Administration, Policy and Regulation (576)
- Social and Behavioral Sciences (523)
- Natural Products Chemistry and Pharmacognosy (506)
- Medical Education (488)
- Physical Sciences and Mathematics (422)
- Pharmaceutical Preparations (356)
- Nursing (307)
- Other Chemicals and Drugs (307)
- Oncology (260)
- Amino Acids, Peptides, and Proteins (251)
- Cell and Developmental Biology (250)
- Pharmacology, Toxicology and Environmental Health (247)
- Chemistry (246)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (245)
- Biochemistry, Biophysics, and Structural Biology (243)
- Medical Pharmacology (231)
- Pharmacoeconomics and Pharmaceutical Economics (220)
- Engineering (210)
- Mental and Social Health (192)
- Institution
-
- University of Kentucky (1065)
- Chapman University (799)
- University of Mississippi (640)
- Chulalongkorn University (384)
- Virginia Commonwealth University (334)
-
- Universitas Indonesia (305)
- University of the Pacific (296)
- Butler University (239)
- Southwestern Oklahoma State University (222)
- Ohio Northern University (218)
- Thomas Jefferson University (215)
- University of South Carolina (213)
- St. John Fisher University (194)
- Nova Southeastern University (193)
- University of Nebraska Medical Center (172)
- Providence (143)
- Parkview Health (141)
- Marshall University (129)
- University of Tennessee Health Science Center (128)
- Purdue University (116)
- Al-Esraa University (101)
- University of Montana (95)
- JSS Academy of Higher Education and Research (92)
- Technological University Dublin (91)
- University of Nebraska - Lincoln (86)
- Aga Khan University (83)
- Baptist Health South Florida (83)
- Campbell University (82)
- Touro College and University System (79)
- Wayne State University (76)
- Keyword
-
- Pharmacy (361)
- Humans (232)
- Aluminum in foods (134)
- Animals (132)
- Cancer (130)
-
- SWOSU (111)
- Male (110)
- Pharmacokinetics (102)
- Female (93)
- COVID-19 (83)
- Pharmacists (83)
- Nanoparticles (79)
- Drug delivery (73)
- Apothecary (68)
- Pharmacology (65)
- Rural (62)
- Antibiotics (61)
- Health care (59)
- Rural Rocks (59)
- Diabetes (57)
- Inflammation (54)
- Treatment (54)
- Department of Pharmacy (53)
- Aluminum content (52)
- Pharmaceutical sciences (52)
- Breast cancer (50)
- Rats (50)
- HIV (46)
- Mice (46)
- Opioid (46)
- Publication Year
- Publication
-
- Pharmacy Faculty Articles and Research (668)
- Theses and Dissertations (381)
- Chulalongkorn University Theses and Dissertations (Chula ETD) (342)
- Electronic Theses and Dissertations (316)
- Pharmaceutical Sciences Faculty Publications (247)
-
- Faculty and Student Publications (193)
- Pharmaceutical Sciences Faculty Patents (193)
- Aluminum in Beverages and Foods: A Compilation (186)
- Pharmacy and Wellness Review (178)
- Pharmaceutical Sciences and Research (175)
- Scholarship and Professional Work – COPHS (170)
- Faculty Publications (166)
- Pharmacy Faculty/Staff Publications (151)
- Theses and Dissertations--Pharmacy (139)
- University of the Pacific Theses and Dissertations (135)
- Theses and Dissertations (ETD) (119)
- Honors Theses (115)
- Al-Esraa University College Journal for Medical Sciences (101)
- School of Pharmacy Faculty Articles (101)
- Theses & Dissertations (100)
- Pharmacy Practice and Science Faculty Publications (92)
- RURAL ROCKS (86)
- Parkview Pharmacy Department (85)
- Biomedical and Pharmaceutical Sciences Faculty Publications (78)
- All Publications (75)
- Apothecary (69)
- HPD Articles (69)
- Pharmaceutical Sciences (66)
- United States Food and Drug Administration: Publications (61)
- Digital Journal of Clinical Medicine (56)
- Publication Type
- File Type
Articles 1921 - 1950 of 9444
Full-Text Articles in Pharmacy and Pharmaceutical Sciences
The Length Of Hospital Stay Of Patients With Venous Thromboembolism: A Cross-Sectional Study From Jordan., Haneen Amawi, Rasha M Arabyat, Sayer Al-Azzam, Toqa Alzu'bi, Hamza Tayseer U'Wais, Alaa M Hammad, Ruba Amawi, Mohammad B. Nusair
The Length Of Hospital Stay Of Patients With Venous Thromboembolism: A Cross-Sectional Study From Jordan., Haneen Amawi, Rasha M Arabyat, Sayer Al-Azzam, Toqa Alzu'bi, Hamza Tayseer U'Wais, Alaa M Hammad, Ruba Amawi, Mohammad B. Nusair
HPD Articles
Background and Objectives: Venous thromboembolism is one of the leading causes of mortality and disability worldwide. Treatment with anticoagulation therapy is essential and requires a delicate approach to select the most appropriate option to improve patient outcomes, including the length of hospital stay (LOS). The aim of this study was to determine the LOS among patients with acute onset of VTE in several public hospitals in Jordan. Materials and Methods: In this study, we recruited hospitalized patients with a confirmed diagnosis of VTE. We reviewed the electronic medical records and charts of VTE admitted patients in addition to a detailed …
The Effects Of A Blood–Brain Barrier Penetrating Erythropoietin In A Mouse Model Of Tauopathy, Joshua Yang, Weijun Ou, Nataraj Jagadeesan, Juste Simanauskaite, Jiahong Sun, Demi M. Castellanos, David H. Cribbs, Rachita K. Sumbria
The Effects Of A Blood–Brain Barrier Penetrating Erythropoietin In A Mouse Model Of Tauopathy, Joshua Yang, Weijun Ou, Nataraj Jagadeesan, Juste Simanauskaite, Jiahong Sun, Demi M. Castellanos, David H. Cribbs, Rachita K. Sumbria
Pharmacy Faculty Articles and Research
Erythropoietin (EPO), a hematopoietic neurotrophin, is a potential therapeutic for Alzheimer’s disease (AD) but has limited blood–brain barrier (BBB) permeability. EPO fused to a chimeric transferrin receptor monoclonal antibody (cTfRMAb) enters the brain via TfR-mediated transcytosis across the BBB. We previously showed that cTfRMAb-EPO is protective in a mouse model of amyloidosis, but its effects on tauopathy are not known. Given that amyloid and tau pathology are characteristics of AD, the effects of cTfRMAb-EPO were studied in a tauopathy mouse model (PS19). Six-month-old PS19 mice were injected intraperitoneally with either saline (PS19-Saline; n = 9) or cTfRMAb-EPO (PS19-cTfRMAb-EPO, 10 mg/kg; …
Intensive Care Unit Mortality And Length Of Stay Among Critically Ill Patients With Sepsis Treated With Corticosteroids: A Retrospective Cohort Study, Eric E. Chinaeke, Ismaeel Yunusa Ph.D., Bryan L. Love Pharm. D., Joseph Magagnoli, Claiborne E. Reeder
Intensive Care Unit Mortality And Length Of Stay Among Critically Ill Patients With Sepsis Treated With Corticosteroids: A Retrospective Cohort Study, Eric E. Chinaeke, Ismaeel Yunusa Ph.D., Bryan L. Love Pharm. D., Joseph Magagnoli, Claiborne E. Reeder
Faculty Publications
Objectives: Sepsis is a major cause of morbidity and mortality in critically ill patients worldwide, and corticosteroids are commonly used to treat it. However, the evidence supporting the use of corticosteroids in sepsis patients admitted to the intensive care unit (ICU) is of low certainty, with conflicting results reported in previous studies. Thus, we aimed to investigate the potential association between corticosteroid treatment and various outcomes, including 30-day ICU mortality, ICU length of stay (LOS), mechanical ventilation use, new onset of infection, and hyperglycemia in patients diagnosed with sepsis and admitted to the ICU.
Materials and Methods: We conducted …
The Polypharmacological Effects Of Cannabidiol, Jorge Castillo-Arellano, Ana Canseco-Alba, Stephen J. Cutler Ph.D., Francisco León Ph.D.
The Polypharmacological Effects Of Cannabidiol, Jorge Castillo-Arellano, Ana Canseco-Alba, Stephen J. Cutler Ph.D., Francisco León Ph.D.
Faculty Publications
Cannabidiol (CBD) is a major phytocannabinoid present in Cannabis sativa (Linneo, 1753). This naturally occurring secondary metabolite does not induce intoxication or exhibit the characteristic profile of drugs of abuse from cannabis like Δ9-tetrahydrocannabinol (∆9-THC) does. In contrast to ∆9-THC, our knowledge of the neuro-molecular mechanisms of CBD is limited, and its pharmacology, which appears to be complex, has not yet been fully elucidated. The study of the pharmacological effects of CBD has grown exponentially in recent years, making it necessary to generate frequently updated reports on this important metabolite. In this article, a …
Development, Optimization, And In Vitro/In Vivo Evaluation Of Azelaic Acid Transethosomal Gel For Antidermatophyte Activity, Ali Nasr, Noha Badawi, Yasmine Tartor, Nader Sobhy, Ali Nasr
Development, Optimization, And In Vitro/In Vivo Evaluation Of Azelaic Acid Transethosomal Gel For Antidermatophyte Activity, Ali Nasr, Noha Badawi, Yasmine Tartor, Nader Sobhy, Ali Nasr
Pharmacy
Treatment of dermatophytosis is quite challenging. This work aims to investigate the antidermatophyte action of Azelaic acid (AzA) and evaluate its efficacy upon entrapment into transethosomes (TEs) and incorporation into a gel to enhance its application. Optimization of formulation variables of TEs was carried out after preparation using the thin film hydration technique. The antidermatophyte activity of AzA-TEs was first evaluated in vitro. In addition, two guinea pig infection models with Trichophyton (T.) mentagrophytes and Microsporum (M.) canis were established for the in vivo assessment. The optimized formula showed a mean particle size of 219.8 ± 4.7 nm and a …
Improving Resident Awareness And Documentation Of Abnormal Involuntary Movements In Psychiatric Patients On Antipsychotic Medications, Jocelyn Mccornack, Kelly Wurzel
Improving Resident Awareness And Documentation Of Abnormal Involuntary Movements In Psychiatric Patients On Antipsychotic Medications, Jocelyn Mccornack, Kelly Wurzel
View All Graduate Medical Education Content
No abstract provided.
Treating Opioid Use Disorder: One Shot At A Time, Shelly Haferkamp, Michael P. Kinney, Daniel Yang, Lindsey Cunningham, Anna Davey, Amy G Burns
Treating Opioid Use Disorder: One Shot At A Time, Shelly Haferkamp, Michael P. Kinney, Daniel Yang, Lindsey Cunningham, Anna Davey, Amy G Burns
View All Graduate Medical Education Content
No abstract provided.
Benzodiazepine-Minimizing Protocol For Alcohol Withdrawal: A Comparative Analysis, Jennifer Gaston, Hsin-Fang Li, Emily J Cox, Caitlin Klamper, John F Wurzel
Benzodiazepine-Minimizing Protocol For Alcohol Withdrawal: A Comparative Analysis, Jennifer Gaston, Hsin-Fang Li, Emily J Cox, Caitlin Klamper, John F Wurzel
View All Graduate Medical Education Content
No abstract provided.
Improving Metabolic Monitoring During Transfers Of Care For Psychiatric Patients Discharged From The Inpatient Psychiatric Residency Service On An Antipsychotic Medication – Part 2, Allison Cohen, Anisha Boetel
Improving Metabolic Monitoring During Transfers Of Care For Psychiatric Patients Discharged From The Inpatient Psychiatric Residency Service On An Antipsychotic Medication – Part 2, Allison Cohen, Anisha Boetel
View All Graduate Medical Education Content
No abstract provided.
Identifying Systemic Errors In Refilling Insulin To Prevent Another Hospitalization: An Rca, John Butler, Mikayla Button, Jared Fincher, Rakin Solaiman, Michael Woodfin
Identifying Systemic Errors In Refilling Insulin To Prevent Another Hospitalization: An Rca, John Butler, Mikayla Button, Jared Fincher, Rakin Solaiman, Michael Woodfin
View All Graduate Medical Education Content
No abstract provided.
Variables Impacting Initial Drug Card Exam Pass Rates, Kyle Shapcott, Maddi Hansen
Variables Impacting Initial Drug Card Exam Pass Rates, Kyle Shapcott, Maddi Hansen
Pharmacy and Allied Health Professions Student Research Publications and Projects
Background and Purpose: Top 200 Drug Card Exams are administered in the professional program at South Dakota State University to prepare students for clinical rotations and board exams.
Methods and Materials: Analysis of several variables was performed to find their impact on initial drug card exam pass rates: first exposure to the exam content, hours spent studying for the exam, average hours worked in a week, and time worked in a pharmacy. Data for this study was collected through an optional survey provided to P1, P2, and P3 students and optional quizzes that were provided to both P1 (n=42) and …
Various Synthetic Pathways Towards Efavirenz And Its Analogs; The Replacement Of The Side Chain, Elizabeth S. Bautista
Various Synthetic Pathways Towards Efavirenz And Its Analogs; The Replacement Of The Side Chain, Elizabeth S. Bautista
Selected Honors Theses
Cyclopropyl acetylene (CA) is a key intermediate in the synthesis of the human immunodeficiency virus (HIV) reverse transcriptase inhibitor, Efavirenz (EFV), an antiviral drug used to treat HIV. CA is an expensive raw material, difficult to obtain, and employed in the preparation of medications to combat acquired immunodeficiency syndrome (AIDS). It was found that the structure could be synthesized by the utilization of PCl5; however, this resulted in unwanted ring opening products. To address this issue, a one pot synthesis was developed using Ph3PCl2 as a mild chlorinating agent. In addition, a new analog has been proposed substituting the cyclopropyl …
Personalizing Prevention: Advances In Pharmacotherapy For Hiv Prevention., Marisa Brizzi, Elizabeth Sherman, Sarah B. Green, Diana N. Nowicki, Emily N. Drwiega, Melanie R. Nicol, Daniel B. Chastain, Eric G. Sahloff, William R. Truong, David Cluck, Melissa E. Badowski, Sarah M. Michienzi, Spencer H. Durham
Personalizing Prevention: Advances In Pharmacotherapy For Hiv Prevention., Marisa Brizzi, Elizabeth Sherman, Sarah B. Green, Diana N. Nowicki, Emily N. Drwiega, Melanie R. Nicol, Daniel B. Chastain, Eric G. Sahloff, William R. Truong, David Cluck, Melissa E. Badowski, Sarah M. Michienzi, Spencer H. Durham
HPD Articles
The HIV epidemic continues to pose a significant burden on the healthcare system. Although the incidence of annual new infections is decreasing, health disparities persist and most new infections remain concentrated into different racial, ethnic, and minority groups. Pre-exposure prophylaxis (PrEP), which involves those at high risk of acquiring HIV to take chronic medications to prevent acquisition of the virus, is key to preventing new HIV infections. The purpose of this article is to review medication therapies for PrEP and examine their role in personalizing PrEP in different patient populations. Additionally, new medications currently under development for PrEP are reviewed, …
Phad 781: Applied Multivariate Analysis, John P. Bentley Ph.D.
Phad 781: Applied Multivariate Analysis, John P. Bentley Ph.D.
GMAS Course Syllabi
No abstract provided.
Controlled Release Of Dna Binding Anticancer Drugs From Gold Nanoparticles With Near-Infrared Radiation, Gracie Fitzgerald, Daniel Low, Luc Morgan, Cole Hilt, Micai Benford, Caleb Akers, Skyler Hornback, J. Zach Hilt, Daniel Scott
Controlled Release Of Dna Binding Anticancer Drugs From Gold Nanoparticles With Near-Infrared Radiation, Gracie Fitzgerald, Daniel Low, Luc Morgan, Cole Hilt, Micai Benford, Caleb Akers, Skyler Hornback, J. Zach Hilt, Daniel Scott
UK CARES Faculty Publications
Traditional chemotherapies target rapidly developing cells in the human body resulting in harsh side effects including fatigue, immune system suppression, and nausea, among others. Delivery systems to focus the active pharmaceutical ingredients (APIs) to the diseased tissue can diminish the negative side effects while improving treatment outcomes. Gold nanoparticles (AuNP) offer many unique advantages as drug delivery vehicles, including being biologically inert, easily adaptable to various shapes and sizes, able to create a strong Au-thiol bond, and able to generate heat upon the absorption of near-infrared light. To this end, a AuNP delivery vehicle was engineered to load and release …
Discrepancies In Age-Based Medication Dosing, Chad Ruger, Anne Keeling, Sera Jacob, Cassidy Macarthur
Discrepancies In Age-Based Medication Dosing, Chad Ruger, Anne Keeling, Sera Jacob, Cassidy Macarthur
Articles, Abstracts, and Reports
No abstract provided.
Qi Project: Clopidogrel In Nstemi, Amanda Sams, Erin Kaya, Carsten Kirby, Ester Peters, Michael Stewart (Faculty Advisor)
Qi Project: Clopidogrel In Nstemi, Amanda Sams, Erin Kaya, Carsten Kirby, Ester Peters, Michael Stewart (Faculty Advisor)
Articles, Abstracts, and Reports
No abstract provided.
Preventable Tacrolimus Toxicity, Brooke Parker, Jessica Sterner, John Mele, Laura Dewald, Cassidy Johnston
Preventable Tacrolimus Toxicity, Brooke Parker, Jessica Sterner, John Mele, Laura Dewald, Cassidy Johnston
Articles, Abstracts, and Reports
No abstract provided.
Single-Center Experience With Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis Against Sars-Cov-2 Infection In Kidney And Pancreas Transplant Recipients, Milisha Shah Pharmd, Bcps, Bctxp, Hope Kincaid Mph, Cph, Alison Sutter Mph, Christine Du Md, Patty Liu Md, Michael J. Moritz Md
Single-Center Experience With Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis Against Sars-Cov-2 Infection In Kidney And Pancreas Transplant Recipients, Milisha Shah Pharmd, Bcps, Bctxp, Hope Kincaid Mph, Cph, Alison Sutter Mph, Christine Du Md, Patty Liu Md, Michael J. Moritz Md
Department of Pharmacy
No abstract provided.
Impacts Of Fda Approval And Medicare Restriction On Antiamyloid Therapies For Alzheimer’S Disease: Patient Outcomes, Healthcare Costs, And Drug Development, Rouen Brockmann, Joanna Nixon, Bryan L. Love Pharm D., Ismaeel Yunusa Ph. D.
Impacts Of Fda Approval And Medicare Restriction On Antiamyloid Therapies For Alzheimer’S Disease: Patient Outcomes, Healthcare Costs, And Drug Development, Rouen Brockmann, Joanna Nixon, Bryan L. Love Pharm D., Ismaeel Yunusa Ph. D.
Faculty Publications
In 2021, the US Food and Drug Administration (FDA) granted approval to aducanumab, an antiamyloid antibody for early-stage Alzheimer's disease, despite a lack of clear clinical evidence demonstrating the drug's cognitive benefits. The manufacturer initially priced the drug at a staggering $56,000 per year, a price that was later reduced to $28,200. Unfortunately, these costs do not include the additional expenses associated with monitoring the treatment. However, the Centers for Medicare and Medicaid Services (CMS) recently announced that they will only cover individuals enrolled in clinical trials and will limit coverage of future antiamyloid antibodies. This discrepancy between the FDA …
Pharmacy Newsletter : April 2023, Pharmacy Department
Pharmacy Newsletter : April 2023, Pharmacy Department
Department of Pharmacy Archives
- Changes in Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report
- TOX-TOK: Sulfonylurea Overdose
- Difference Between Parenteral Iron Products
- Drug-Drug Interactions Impacting the Treatment of HIV-TB Co-Infection
- Conversion Between Different Corticosteroid Preparations
- Use of Analgesics in Adult Patients with Cirrhosis
Sharksrx Newsletter Spring 2023, Nova Southeastern University
Sharksrx Newsletter Spring 2023, Nova Southeastern University
NSU Sharks Rx
No abstract provided.
Targeting Of Mediator Kinases For Cancer Therapy And Resistance Prevention, Zachary Thomas Mack
Targeting Of Mediator Kinases For Cancer Therapy And Resistance Prevention, Zachary Thomas Mack
Theses and Dissertations
Estrogen receptor (ER)-positive breast cancers make up 70% of all breast cancer incidences in the US. Cell cycle progression of ER-positive breast cancer is highly dependent on cyclin-dependent kinases (CDK) 4 and 6, the G1/S checkpoint kinases. Inhibitors of CDK4/6 have become a major addition to the clinical arsenal against ER-positive breast cancers. CDK4/6 inhibitor palbociclib (IBRANCETM) has been approved for the treatment of ER-positive breast cancers. However, palbociclib treatment eventually fails due to the development of resistance. Laboratory studies revealed several diverse mechanisms of palbociclib resistance, making universal re-sensitization difficult to achieve. However, prevention of the adaptive process that …
Iv Dexamethasone To Assist With Post Operative Pain And Nausea, Tasha Coumbs
Iv Dexamethasone To Assist With Post Operative Pain And Nausea, Tasha Coumbs
Articles, Abstracts, and Reports
No abstract provided.
A Metabolic, Mechanical, Multi-Organ Masterpiece: Dural Device Support Bridge To En-Bloc Heart-Liver Transplantation In Propionic Acidemia, Rebecca Juhl, Brian Birnbaum, Aliessa P. Barnes, William Gibson, Bhargava Mullapudi, Beth Lang, Megan Faseler, Daniel E. Heble, Victoria Urban, Ryan T. Fischer, Jennifer L. Gannon, David Sutcliffe
A Metabolic, Mechanical, Multi-Organ Masterpiece: Dural Device Support Bridge To En-Bloc Heart-Liver Transplantation In Propionic Acidemia, Rebecca Juhl, Brian Birnbaum, Aliessa P. Barnes, William Gibson, Bhargava Mullapudi, Beth Lang, Megan Faseler, Daniel E. Heble, Victoria Urban, Ryan T. Fischer, Jennifer L. Gannon, David Sutcliffe
Posters
Introduction: Propionic Acidemia (PA) is a disorder related to abnormal protein and lipid metabolism resulting in progressive neurological injury and dilated cardiomyopathy (DCM). Interventions for PA and secondary disease manifestations can require multi-organ transplantation. Herein we report the case of a child with PA and end-stage DCM requiring left ventricular assist device (LVAD) support with eventual heart-liver transplant. Case Report: A 17 year old male diagnosed in childhood with PA developed chronically progressive DCM culminating in end stage heart failure with acute decompensations. In a recurrent admission, he progressed to require dual inotropic support and systemic anticoagulation for new LV …
Comparison Of Nimodipine Formulations And Administration Techniques Via Enteral Feeding Tubes In Patients With Aneurysmal Subarachnoid Hemorrhage: A Multicenter Retrospective Cohort Study., Sherif Hanafy Mahmoud, Fatma R Hefny, Nicholas G Panos, Laura Delucilla, Zinquon Ngan, Marc M Perreault, Leslie A Hamilton, A Shaun Rowe, Pamela L Buschur, Jocelyn Owusu-Guha, Sulaiman Almohaish, Melissa Sandler, Michael J Armahizer, Megan E Barra, Aaron M Cook, Colleen A Barthol, Trager D Hintze, Anna Cantin, Jessica Traeger, Joseph R Blunck, Justin Shewmaker, Sarah V Burgess, Kristin Kaupp, Caitlin S Brown, Sarah L Clark, Erin D Wieruszewski, Eljim P Tesoro, Abdalla A Ammar, Mahmoud A Ammar, Mandy J Binning, Stanislav Naydin, Neal Fox, David M Peters, Leana N Mahmoud, Shaun P Keegan, Gretchen M Brophy
Comparison Of Nimodipine Formulations And Administration Techniques Via Enteral Feeding Tubes In Patients With Aneurysmal Subarachnoid Hemorrhage: A Multicenter Retrospective Cohort Study., Sherif Hanafy Mahmoud, Fatma R Hefny, Nicholas G Panos, Laura Delucilla, Zinquon Ngan, Marc M Perreault, Leslie A Hamilton, A Shaun Rowe, Pamela L Buschur, Jocelyn Owusu-Guha, Sulaiman Almohaish, Melissa Sandler, Michael J Armahizer, Megan E Barra, Aaron M Cook, Colleen A Barthol, Trager D Hintze, Anna Cantin, Jessica Traeger, Joseph R Blunck, Justin Shewmaker, Sarah V Burgess, Kristin Kaupp, Caitlin S Brown, Sarah L Clark, Erin D Wieruszewski, Eljim P Tesoro, Abdalla A Ammar, Mahmoud A Ammar, Mandy J Binning, Stanislav Naydin, Neal Fox, David M Peters, Leana N Mahmoud, Shaun P Keegan, Gretchen M Brophy
Pharmacy Articles
BACKGROUND: Nimodipine improves outcomes following aneurysmal subarachnoid hemorrhage (aSAH) and current guidelines suggest that patients with aSAH receive nimodipine for 21 days. Patients with no difficulty swallowing will swallow the whole capsules or tablets; otherwise, nimodipine liquid must be drawn from capsules, tablets need to be crushed, or the commercially available liquid product be used to facilitate administration through an enteral feeding tube (FT). It is not clear whether these techniques are equivalent. The goal of the study was to determine if different nimodipine formulations and administration techniques were associated with the safety and effectiveness of nimodipine in aSAH.
METHODS: …
March / April 2023, Randy Curry, Cindy Brooks
March / April 2023, Randy Curry, Cindy Brooks
RURAL ROCKS
This is the March & April 2023 issue of Rural Rocks from the SWOSU College of Pharmacy.
Well-Being Content Inclusion In Pharmacy Education Across The United States And Canada, Elizabeth Buckley, Simi Gunaseelan, Benjamin D Aronson, Heidi N Anksorus, Victoria Belousova, Tram B Cat, Kristine M Cline, Stacey D Curtis, Christina E Deremer, David Fuentes, Mckenzie S Grinalds, Seena L Haines, Hannah E Johnson, Karen Kopacek, Jessica M Louie, Nkem P Nonyel, Natasha Petry, Shawn Riser Taylor, Suzanne C Harris, Cheryl A Sadowski, Anandi V Law
Well-Being Content Inclusion In Pharmacy Education Across The United States And Canada, Elizabeth Buckley, Simi Gunaseelan, Benjamin D Aronson, Heidi N Anksorus, Victoria Belousova, Tram B Cat, Kristine M Cline, Stacey D Curtis, Christina E Deremer, David Fuentes, Mckenzie S Grinalds, Seena L Haines, Hannah E Johnson, Karen Kopacek, Jessica M Louie, Nkem P Nonyel, Natasha Petry, Shawn Riser Taylor, Suzanne C Harris, Cheryl A Sadowski, Anandi V Law
Faculty, Staff and Student Publications
Objective. To describe the landscape of well-being content inclusion across schools and colleges of pharmacy in the United States and Canada through identification of content implementation, incorporation, and assessment.
Methods. A cross-sectional survey was distributed to all accredited schools and colleges of pharmacy in the United States (n=143) and Canada (n=10). Survey questions included curricular and cocurricular timing, frequency, assessment strategies, and support for well-being initiatives, using a framework of eight dimensions (pillars) of wellness to categorize content.
Results. Descriptive data analyses were applied to 99 completed surveys (65%), 89 (62%) in the United States and 10 (100%) in Canada. …
Computational Evaluation Of Bioactive Compounds From Vaccinium Vitis-Idaea L (Ligonberry) For Treating Kras-Associated Lung Cancer, Ayooluwa Ilesanmi, Gbenga Dairo, Toheeb Balogun, Bibiire Awoyale
Computational Evaluation Of Bioactive Compounds From Vaccinium Vitis-Idaea L (Ligonberry) For Treating Kras-Associated Lung Cancer, Ayooluwa Ilesanmi, Gbenga Dairo, Toheeb Balogun, Bibiire Awoyale
Undergraduate Research Conference
Lung cancer is the cancer of the lung's epithelial cells typically characterized by difficult breathing, chest pain, blood-stained coughs, headache, and weight loss. If left unmanaged, lung cancer can spread to other body parts. While several treatment methods exist for managing lung cancer, exploring natural plant sources for developing therapeutics offers great potential in complementing different treatment approaches. In this study, we concentrated on inhibiting the mutated Kirsten rat sarcoma viral oncogene homolog (KRAS) by targeting an associated protein (Phosphodiesterase 6δ) to which KRAS form complexes. We evaluated bioactive compounds from Lingonberry (Vaccinium vitis-idaea L), adopting computational approaches such as …
Up-02 Pharmacological And Non-Pharmacological Interventions For The Treatment Of Neonatal Abstinence Syndrome, Taylor Meetze, Reagan Bradley, Peyton Smith, Emily Sisk, Ryan Crawford
Up-02 Pharmacological And Non-Pharmacological Interventions For The Treatment Of Neonatal Abstinence Syndrome, Taylor Meetze, Reagan Bradley, Peyton Smith, Emily Sisk, Ryan Crawford
SC Upstate Research Symposium
Background: Newborns diagnosed with Neonatal Abstinence Syndrome (NAS) often experience extreme symptoms as their body’s withdrawals from substances. Pharmacological and non-pharmacological interventions are provided that aim to treat NAS. However, nurses should be aware of what treatment leads to better outcomes and shorter hospitalization.
Aim: The aim of the project was to compare the length of hospitalization of pharmacological and non-pharmacological interventions for newborns with mild NAS.
Methods: The team of researchers devised a research question to guide a search in the Cumulative Index of Nursing and Allied Health Literature (CINAHL) to identify relevant literature focused on pharmacological …